A detailed history of Kestra Advisory Services, LLC transactions in Galera Therapeutics, Inc. stock. As of the latest transaction made, Kestra Advisory Services, LLC holds 32,250 shares of GRTX stock, worth $4,515. This represents 0.0% of its overall portfolio holdings.

Number of Shares
32,250
Previous 35,750 9.79%
Holding current value
$4,515
Previous $5,000 20.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$0.14 - $0.27 $490 - $945
-3,500 Reduced 9.79%
32,250 $4,000
Q4 2023

Feb 14, 2024

SELL
$0.09 - $0.27 $4,500 - $13,500
-50,000 Reduced 58.31%
35,750 $5,000
Q3 2023

Nov 09, 2023

BUY
$0.17 - $3.0 $14,577 - $257,250
85,750 New
85,750 $15,000

Others Institutions Holding GRTX

About Galera Therapeutics, Inc.


  • Ticker GRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,821,600
  • Market Cap $3.76M
  • Description
  • Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...
More about GRTX
Track This Portfolio

Track Kestra Advisory Services, LLC Portfolio

Follow Kestra Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kestra Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kestra Advisory Services, LLC with notifications on news.